Latest Growth Initiatives News

HiTech Group Australia Limited has reported a robust half-year performance with a 29% increase in net profit and a strategic focus on high-margin ICT services amid growing market demand.

Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.

Audinate’s 1H25 results surpassed market expectations despite a 29% drop in gross profit, driven by a strategic shift towards higher-margin software products and a robust cash position.

Audinate delivered 1H25 results above guidance despite a transitional year marked by inventory adjustments, with software revenue growth and strategic product launches setting the stage for a return to growth in FY26.

BlueScope reported a $179 million net profit for 1H FY2025 amid challenging steel market conditions, while announcing a 30 cents per share dividend and a $240 million buy-back plan. The company is banking on cost initiatives and market recovery to boost earnings in the second half.

Abacus Storage King reported a striking turnaround with a $67.8 million net profit for H1 2024, up from just $0.4 million a year earlier, alongside a raised interim distribution reflecting robust growth in the self-storage sector.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.

GQG Partners Inc. reported strong financial results for 2024, with significant increases in revenue, net income, and funds under management, alongside a raised dividend and strategic moves including the deconsolidation of its PCS Master Fund.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.